Clinicians' views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study.

ABSTRACT:

Background

Bisphosphonate medications, including alendronate, ibandronate and risedronate administered orally and zoledronate, administered intravenously, are commonly prescribed for the treatment of osteoporosis based on evidence that, correctly taken, bisphosphonates can improve bone strength and lead to a reduction in the risk of fragility fractures. However, it is currently unclear how decisions to select between bisphosphonate regimens, including intravenous regimen, are made in practice and how clinicians support patients with different treatments.

Methods

This was an interpretivist qualitative study. 23 semi-structured telephone interviews were conducted with a sample of general practitioners (GPs), secondary care clinicians, specialist experts as well as those provid

SUBMITTER: Bishop S 

PROVIDER: S-EPMC10540377 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature